By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Relmada Therapeutics 

  New York    U.S.A.
Phone: n/a Fax: n/a


Company News
Relmada Therapeutics Secures First European Patent Covering LevoCap ER 7/6/2016 7:41:16 AM
Relmada Therapeutics Announces Notice Of Allowance For U.S. Patent Covering D-Methadone, An NMDA Receptor Antagonist, For The Treatment Of Depression 6/27/2016 8:47:52 AM
Relmada Therapeutics' d-Methadone Receives Orphan Drug Designation For Management Of Postherpetic Neuralgia 6/7/2016 11:10:14 AM
Relmada Therapeutics To Present At The LD Micro Invitational Conference 6/1/2016 1:29:30 PM
Relmada Therapeutics To Present At The 5th Annual Marcum MicroCap Conference 5/26/2016 8:16:08 AM
Relmada Therapeutics Announces Promotion Of Michael D. Becker To Chief Financial Officer 5/16/2016 6:52:41 AM
Relmada Therapeutics Announces Results Of In Vivo Study Showing d-Methadone Has Antidepressant-like Effects 5/4/2016 6:52:23 AM
Relmada Therapeutics To Present At The Joseph Gunnar "Pioneers 2016" Conference 4/28/2016 9:53:19 AM
Relmada Therapeutics Provides Additional Details Regarding Upcoming R&D Day 4/26/2016 10:18:32 AM
Relmada Therapeutics To Showcase Breadth Of Pipeline At Upcoming R&D Day 4/20/2016 8:05:25 AM